Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus I Infection”

332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 332 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Early research (Phase 1)Study completedNCT00000984
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT00001785
What this trial is testing

Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Who this might be right for
HTLV-I InfectionSpinal Cord DiseaseTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Not applicableStudy completedNCT05248100
What this trial is testing

Rudi Kundini, Pamoja Kundini: Phase I

Who this might be right for
HIV (Human Immunodeficiency Virus)
University of California, Berkeley 567
Not applicableStudy completedNCT05383456
What this trial is testing

The Visceral Adiposity Measurement and Observation Study

Who this might be right for
HIVHIV-InfectionsHIV-1-infection+16 more
Theratechnologies 196
Early research (Phase 1)Study completedNCT00352066
What this trial is testing

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Who this might be right for
HIV Infection
Avexa 18
Testing effectiveness (Phase 2)Ended earlyNCT00104429
What this trial is testing

GW873140 In Combination With Combivir In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 125
Early research (Phase 1)WithdrawnNCT02343666
What this trial is testing

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

Who this might be right for
Human Immunodeficiency Virus 1 PositiveStage I Adult Hodgkin LymphomaStage I Adult Non-Hodgkin Lymphoma+6 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT04725877
What this trial is testing

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

Who this might be right for
HIV I Infection
Vir Biotechnology, Inc. 27
Testing effectiveness (Phase 2)Study completedNCT02038842
What this trial is testing

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 92
Early research (Phase 1)Study completedNCT03844386
What this trial is testing

Study to Assess Safety and Ability to Induce Immune Responses of HIV-1 Vaccines M3 and M4 Given Alone or in Combination in HIV-infected Adults

Who this might be right for
HIV-1 Infection
University of North Carolina, Chapel Hill 26
Not applicableStudy completedNCT06368453
What this trial is testing

Evaluate the Performance, Usability, and Result Interpretation of INSTI® HIV Self-Test

Who this might be right for
Human Immunodeficiency Virus I InfectionHuman Immunodeficiency Virus II Infection
bioLytical Laboratories 1,728
Large-scale testing (Phase 3)Study completedNCT00044577
What this trial is testing

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 166
Early research (Phase 1)Study completedNCT00000957
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Not Yet RecruitingNCT07392372
What this trial is testing

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

Who this might be right for
HIV -1 Infection
BioNTech SE 61
Testing effectiveness (Phase 2)Study completedNCT02471430
What this trial is testing

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy

Who this might be right for
HIV Infection
Massachusetts General Hospital 17
Load More Results